HIV molecular immunology database


Patient Detail

Patient Code R039
Patient Sex
Risk Factor
Infection Country GB
Infection City
Infection Year 2006
HLA Type A*01:01, A*31:01, B*27:05, B*57:01, C*02:02, C*06:02
Patient Ethnicity
Progression Elite Controller (EC)
Species human
Patient Note Treatment-naive, chronic HIV-1 infected patient R039 was tested at 9 months post-infection, viral load = 204 RNA copies/ml; at 12 months post-infection, CD4+ count = 650 cells/ml. Magnitudes of CTL response were 535 Sfu/million PBMC against OLP WVKVVEEKAFSPEVIPMF (containing Gag epitope KAFSPEVIPMF); 615 Sfu/million PBMC against OLP PVGEIYKRWIILGLNKIV (containing Gag epitope KRWIILGLNK), 235 Sfu/million PBMC against OLP LWVYHTQGYFPDWQNY (containing Nef epitope HTQGYFPDW), and 615 Sfu/million PBMC against OLP AVFIHNFKRKGGIGGYSA (containing Pol epitope KRKGGIGGY). Magnitudes of CTL response using EliSpot against optimal epitopes was 520 Sfu/ million PBMC for KAFSPEVIPMF, 320 Sfu/ million PBMC for KRWIILGLNK and 1,180 Sfu/million PBMC for KRKGGIGGY. Cells from R039 were used to generate a KF11-specific CTL cell line as well as a B-cell line.
CTL CD8+ Records 58676, 59010, 59030, 59031
T-Helper CD4+ Records
Antibody Records
Sequence Database Patient ID Record
Questions or comments? Contact us at
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health